Please try another search
For the three months ended 31 March 2022, Enbio Co Ltd revenues increased 32% to W20.28B. Net income decreased 41% to W3.99B. Revenues reflect herbicides segment increase from W2.6B to W5.6B, insecticide segment increase of 51% to W4.92B, South Korea (Country) segment increase of 33% to W19.41B, other foreign countries segment increase of 20% to W864.4M. Net income was offset by Selling & Administrative Expense increase of 37% to W3.01B (expense).
Period Ending: | Dec 31, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
---|---|---|---|---|
Total Revenue | 20216.23 | 4411.59 | 8503.51 | |
Gross Profit | 10582.35 | -3507.76 | 3232.3 | |
Operating Income | 7394.33 | -5828.05 | 258.66 | |
Net Income | 5129.89 | -3262.73 | -364.25 |
Period Ending: | Dec 31, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
---|---|---|---|---|
Total Assets | 97800.91 | 87359.61 | 93782.72 | |
Total Liabilities | 46182.54 | 40871.13 | 44049.38 | |
Total Equity | 51618.37 | 46488.48 | 49733.34 |
Period Ending: | Dec 31, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 1805.38 | 701.36 | -6899.5 | |
Cash From Investing Activities | 1919.72 | -2549.51 | -136.16 | |
Cash From Financing Activities | 759.64 | -1942.57 | 3979.3 | |
Net Change in Cash | 4487.57 | -3805.19 | -3066.59 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review